QuarterWatch Clarifications and Corrections

April 2016

This issue was revised on April 27, 2015 to correct the 95% confidence interval (CI) in Table 2 of the item on phosphodiesterase inhibitors and sudden hearing loss. The confidence interval for the odds ratio for sildenafil should be 3.9-11.9. The corrected version of the April 2016 QuarterWatch has the file name of 2015Q3R1.

January 2015

This issue was revised on February 8, 2015 to reflect the following specific changes: On page 8, the caption for Figure 1 should state that the horizontal line in each box indicates the median value for each outcome rather than the industry average as stated. On page 19, the disclosure statement for Curt D. Furberg provided the incorrect generic name for Actos, which should be pioglitazone rather than rosiglitazone. The corrected version of QuarterWatch contains the file name 2014Q1r1.



Home | Contact UsEmployment  |   Legal Notices | Privacy Policy | Help Support ISMP
 Med-ERRS | Medication Safety Officer Society Medication Safety Officers Society | Consumer Medication Safety For consumers
ISMP Canada | ISMP Spain  | ISMP Brasil  | International Group  | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2018 Institute for Safe Medication Practices. All rights reserved